INSIGHTS ON SOLID DOSE MANUFACTURING
-
Oral Delivery Of PROTACs: Integrating Molecular Design And Enabling Formulation
Explore how integrated molecular design and formulation strategies can overcome the unique oral-delivery challenges of PROTACs, transforming complex degraders into viable, scalable medicines.
-
Layer By Layer: 3D Screen Printing And The Future Of Drug Development
3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.
-
Precision In Miniature: Optimizing Multiparticulate Formulations For Pediatric Oncology
When an oral liquid formulation of crizotinib failed pediatric trials due to intolerable taste and irritation, a multiparticulate approach offered a technically demanding but viable path forward.
-
Shaping The Future Of Solid Dose Manufacturing With Hot Melt Extrusion
Enhance your drug development strategies today and master hot melt extrusion by learning about excipient selection, equipment setup, novel screening tools, and process optimization.
-
Beyond Development: Using Continuous Manufacturing To Accelerate OSD Commercialization8/31/2026
Hear firsthand insights from Douglas B. Hausner, Ph.D., Senior Manager of Continuous Manufacturing, on the company’s first OSD product submission enabled by continuous manufacturing and Real-Time Release Testing.
-
How To Solve Complex Pediatric Dosing Challenges Using Tailored Solutions8/11/2025
With a partner who understands the science, the regulations, and the real-world demands of dosing children, development can move faster, smarter, and with greater confidence
-
Navigating High-Potency OSD Manufacturing4/13/2026
Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.
-
Accelerating An Innovative High Potency Oncology Therapy To Market5/13/2026
Assimilate how disciplined containment, proactive risk management, and collaboration accelerate oncology programs under tight timelines while protecting quality, safety, and global launch readiness.
-
Improving API Solubility Using Hot Melt Extrusion Formulation2/27/2025
Solubility of active pharmaceutical ingredients (APIs) is a challenge in drug development. Discover how hot melt extrusion with polyvinyl alcohol enhances API solubility and stability to offer improved drug delivery.
SOLID DOSE MANUFACTURING SOLUTIONS
-
Highly potent compounds demand specialized containment, risk management, and manufacturing expertise to support safe, efficient development and scalable commercial production.
-
Inno4Life, part of the Dec Group, has in-depth knowledge and containment equipment solutions for the aseptic/sterile Fill-Finish pharmaceutical industry. In line with ISO 14644, including monitoring of viable and non-viable monitoring to comply with the most recent revisions of the ISPE containment specifications cGMP and GAMP5 guidelines.
-
Ensure sterile integrity and personnel safety during hazardous drug handling. Optimize workflows with advanced containment technology that adapts to complex facility and processing requirements.
-
Dec provides liquid & powder filling solutions for the pharmaceutical aseptic/sterile Fill-Finish process. From standard to custom-tailored equipment solutions Dec‘s engineered microdosing and containment system technologies are designed to meet your particular needs for sterile primary packaging.
-
From the incoming materials handling to the final packaging, Dec offers efficient and reliable solutions without altering product characteristics and adapted to specific containment needs.